Once-Weekly Exenatide in Youth With Type 2 Diabetes

OBJECTIVE: Approved treatments for type 2 diabetes in pediatric patients include metformin, liraglutide, and insulin. However, approximately one-half of the youth fail metformin monotherapy within 1 year, insulin therapy is associated with challenges, and liraglutide requires daily injections. Conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamborlane, William V., Bishai, Raafat, Geller, David, Shehadeh, Naim, Al-Abdulrazzaq, Dalia, Vazquez, Evelina Mánica, Karoly, Eva, Troja, Tünde, Doehring, Orlando, Carter, Debra, Monyak, John, Sjöström, C. David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
Emerging Therapies: Drugs and Regimens
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346995/
https://www.ncbi.nlm.nih.gov/pubmed/35679098
http://dx.doi.org/10.2337/dc21-2275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346995/
https://www.ncbi.nlm.nih.gov/pubmed/35679098
http://dx.doi.org/10.2337/dc21-2275

Ejemplares similares